Related Experiment Video
Updated: Jul 25, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Cortical and subcortical T2 shortening in multiple sclerosis
1Department of Radiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
AJNR. American Journal of Neuroradiology
|January 1, 1997
Summary
T2 shortening, a magnetic resonance imaging finding, is observed in deep gray matter in multiple sclerosis patients, suggesting neural degeneration. This nonspecific process may also affect cortical and white matter areas in severe cases.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- Magnetic Resonance Imaging (MRI) is crucial for diagnosing and monitoring MS.
- Deep gray matter (DGM) involvement in MS is increasingly recognized.
Observation:
- Low signal intensity on long-repetition-time (T2-weighted) MRI sequences is a known finding in DGM structures in MS patients.
- This T2 shortening is often considered a nonspecific sign of neural degeneration.
- Recently, T2 shortening was observed in the pericentral cortical gray matter and subcortical white matter in a patient with severe MS.
Findings:
- T2 shortening in DGM structures in MS is likely indicative of a degenerative process.
- The observation of T2 shortening in cortical and subcortical regions suggests this may be an additional manifestation of neural degeneration in severe MS.
- This finding contributes to understanding the diverse patterns of neurodegeneration in MS.
Implications:
- Further research is needed to elucidate the precise mechanisms and clinical significance of T2 shortening in various MS brain regions.
- This observation may prompt further investigation into the extent and impact of cortical and subcortical degeneration in MS.
- Understanding these imaging markers can aid in developing more accurate prognostic tools and therapeutic strategies for MS.

